Inventor · disambiguated record
Luxuan Guo Buren
Also filed as: BUREN LUXUAN GUO
6 granted patents·3 pending applications·43 citations·filing 2018–2025
82Inventor score
Top patents by PatentIndex Score
9 records- 0194US11253547B2CD19-directed chimeric antigen receptors and uses thereof in immunotherapyNKARTA INC·Filed 2020·Granted Feb 22, 2022·11 cites·19 claims
- 0294US11154575B2Cancer immunotherapy using CD19-directed chimeric antigen receptorsNKARTA INC·Filed 2020·Granted Oct 26, 2021·10 cites·25 claims
- 0394US11141436B2Immune cells engineered to express CD19-directed chimeric antigen receptors and uses thereof in immunotherapyNKARTA INC·Filed 2020·Granted Oct 12, 2021·8 cites·16 claims
- 0492US11365236B2Truncated NKG2D chimeric receptors and uses thereof in natural killer cell immunotherapyNAT UNIV SINGAPORE·Filed 2018·Granted Jun 21, 2022·13 cites·6 claims
- 0589US12398187B2CD19-directed chimeric antigen receptors and uses thereof in immunotherapyNKARTA INC·Filed 2022·Granted Aug 26, 2025·1 cites·24 claims
- 0675US2025296970A1Cd19-directed chimeric antigen receptors and uses thereof in immunotherapyNKARTA INC·Filed 2025·Application pending·0 cites
- 0773US12351617B2Immune cells comprising truncated NKG2D chimeric receptorsNAT UNIV SINGAPORE·Filed 2022·Granted Jul 8, 2025·0 cites·8 claims
- 0872US2025388645A1Immune Cells Comprising Truncated NKG2D Chimeric ReceptorsNAT UNIV SINGAPORE·Filed 2025·Application pending·0 cites
- 0959US2023390392A1Multiplex gene edited cells for cd70-directed cancer immunotherapyNKARTA INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Luxuan Guo Buren files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →